The effect of spearmint-ginger capsule on ?incidence and severity of oral mucositis

The effect of spearmint-ginger capsule on ?incidence and severity of oral mucositis in patients with breast ?cancer undergoing chemotherapy in Tohid Medical Center, Sanandaj, ??2018

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180215038741N2

Enrollment

Registered

2018-10-24

Start date

2018-07-05

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer patients. Malignant neoplasm of breast

Interventions

Intervention 1: Intervention group: combination of spearmint _ Ginger capsules 500 mg containing 250 mg of ginger and 250 mg spearmint powder, every day two capsules will be given to chemotherapy pati

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: History of at least one course of chemotherapy Definitive diagnosis of breast cancer by clinical trials and an oncologist

Exclusion criteria

Exclusion criteria: Having a history of allergy to ginger or mint and taking them over the past week Metastasis to other organs of other body systems

Design outcomes

Primary

Measure	Time frame
Occurrence of mucositis, severity of mucositis. Timepoint: The first day of chemotherapy, five days after chemotherapy, ten days after chemotherapy, fourteen days after chemotherapy. Method of measurement: A questionnaire, an information recording form and Oral Health Index (OHI).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHavre Mawloudi

Sanandaj University of Medical Sciences

Mawloudi.h@muk.ac.ir+98 87 3633 5014

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026